XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDER'S EQUITY (DEFICIT) - USD ($)
$ in Thousands
Series A convertible preferred stock
Series A-1 convertible preferred stock
Series A-2 convertible preferred stock
Series B convertible preferred stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Beginning Balances at Dec. 31, 2020         $ 1 $ 222 $ (68,220) $ (187) $ (68,184)
Beginning Balances (in shares) at Dec. 31, 2020         538,793        
Shareholders' Equity                  
Exercise of stock options           14     $ 14
Exercise of stock options (in shares)         20,787       20,787
Equity-based compensation           98     $ 98
Other comprehensive loss               (5) (5)
Net (loss) income             223   223
Ending Balances at Mar. 31, 2021         $ 1 334 (67,997) (192) (67,854)
Ending Balances (in shares) at Mar. 31, 2021         559,580        
Beginning Balances at Dec. 31, 2020 $ 4,616 $ 5,398 $ 5,809 $ 39,547          
Beginning Balances (in shares) at Dec. 31, 2020 2,819,027 3,730,366 3,565,063 30,409,890          
Ending Balances at Mar. 31, 2021 $ 4,616 $ 5,398 $ 5,809 $ 39,547          
Ending Balances (in shares) at Mar. 31, 2021 2,819,027 3,730,366 3,565,063 30,409,890          
Beginning Balances at Dec. 31, 2021         $ 22 145,453 (94,004) (198) 51,273
Beginning Balances (in shares) at Dec. 31, 2021         22,230,032        
Shareholders' Equity                  
Exercise of stock options           303     $ 303
Exercise of stock options (in shares)         348,552       348,552
Equity-based compensation           1,001     $ 1,001
Other comprehensive loss               1 1
Net (loss) income             (3,838)   (3,838)
Ending Balances at Mar. 31, 2022         $ 22 $ 146,757 $ (97,842) $ (197) $ 48,740
Ending Balances (in shares) at Mar. 31, 2022         22,578,584